newsfilter
← Latest News
ACCESS Newswire·

Lexaria Oral Nicotine Study NIC-A21-1 Delivers Outstanding Results

DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controls Peak levels achieved were up to 10x higher than controls KELOWNA, BC / ACCESSWIRE / October 5, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "